| Videos taken by TS Elliott at the Grand Opening
http://www.cordblood-america.com/grandopening
11 of 25 new cyrogenic storage tanks being installed at CBAI's new facility in LasVegas
-dated 12/5/09
Share Structure: Transfer Agent: Interwest Transfer Co. (801) - 272-9294
(gagged by the company)
AS: 6.945,000,000
OS: 4,886,468,478 as of Dec 30, 2009 (per 12/31/09 S-1 dilution of 318M in the last 50days )
OS: 4,568,253,327 as of Nov 09, 2009 (per 11/03/09 10Q - dilution of 1.95B in the lst 3 months)
OS: 2,611,087,327 as of Aug 10, 2009 (per 8/14/09 10Q - dilution of 1.03B in the lst 3 months)
10/01/2009 e-mail from IR re dilution... #msg-42102303
Market Capitalization: $93 Million dollars (4.886B x .019pps)
Revenues:
2009: $2,594,126 (9 months 3nding sept 30)
2008: $4,169,949
2007: $5,811,267
2006: $3,328,336
2005: $2,099,463
Recent Press: | Date | Time | Source | Headline | | 02/08/2010 | 5:00AM | PRNUS | Cord Blood America Finalizes Cord Blood Stem Cell Processing and Storage Agreement with BioCells, a Major South American Company | | 01/28/2010 | 6:01AM | EDGAR | - Withdrawal of Registration Statement (RW) | | 01/26/2010 | 12:14PM | PRNUS | Cord Blood America Grand Opening Available for Investor Viewing | | 01/26/2010 | 6:00AM | PRNUS | Cord Blood America Announces $6 Million in Notes Retired | | 01/21/2010 | 6:15PM | PRNUS | Cord Blood America Grand Opening on January 22, 2010: Rain or Shine! | | 01/21/2010 | 6:00AM | PRNUS | Cord Blood America Announces Contract With BioE; Provides Clients Highest Quality, 'State of the Art' Processing System for Cord | | 01/19/2010 | 6:00AM | PRNUS | Cord Blood America Contracts With Center for Stem Cell Awareness to Sell Collection and Storage Services in Florida | | 01/15/2010 | 6:00AM | PRNUS | Cord Blood America Announces Schedule for Grand Opening of Laboratory on January 22, 2010 | | 01/14/2010 | 4:14PM | Form (4) | - Statement of Changes in Beneficial Ownership | | 01/14/2010 | 4:13PM | Form (4) | - Statement of Changes in Beneficial Ownership | | 01/13/2010 | 2:00PM | PRNUS | Cord Blood America Sets Business Strategy for a Successful 2010 | | 01/12/2010 | 10:41AM | EDGAR | - Amended Current report filing (8-K/A) | | 01/11/2010 | 5:16PM | Form (8-K) | - Current report filing | | 01/11/2010 | 8:47AM | PRNUS | Cord Blood America Completes Financings for 2010 Acquisition, Growth Strategy | | 01/07/2010 | 5:03PM | Form (8-K) | - Current report filing | | 01/06/2010 | 9:05AM | PRNUS | Cord Blood America Announces $1.35 Million Note Retired | | 01/06/2010 | 9:00AM | MWUS | (OTC: KKUR) Mayo Clinic Research Proves and Confirms ChromoCure's Technology | | 01/05/2010 | 10:04AM | MWUS | CEO of Cord Blood America (OTCBB: CBAI) Reveals His Company Has Voracious Appetite for Growth, Expansion and Acquisitions | | 01/04/2010 | 8:55AM | PRNUS | Cord Blood America Announces Cord Blood Stem Cell Processing and Storage Agreement With BioCells, a South American Company | | 12/31/2009 | 12:05PM | EDGAR | - Securities Registration Statement (S-1) | | 12/30/2009 | 1:43PM | EDGAR | - Securities Registration: Employee Benefit Plan (S-8) | | 12/29/2009 | 12:59PM | EDGAR | - Withdrawal of Registration Statement (RW) | | 12/16/2009 | 9:00AM | PRNUS | Cord Blood America Says 2009 Debt Reduction Tops $10 Million | | 12/08/2009 | 9:32AM | PRNUS | Cord Blood America Announces Grand Opening of Lab, Corporate Offices on January 22, 2010 | | 12/04/2009 | 5:00AM | MWUS | MoneyTV With Donald Baillargeon, 12/4 | | 11/23/2009 | 8:00AM | PRNUS | Cord Blood America CEO Matthew Schissler Interviewed on Company's Progress | | 11/16/2009 | 8:09AM | PRNUS | Cord Blood America Announces Debt Down; Gross Margins Up: Balance Sheet Significantly Improved | | 11/13/2009 | 4:52PM | Form (10-Q) | - Quarterly Report | | 11/06/2009 | 5:00AM | PRNUS | Cord Blood America Updates Advantages of Las Vegas Laboratory in Analyst Interview; Explains Recent S1 Filing | | 11/03/2009 | 1:37PM | EDGAR | - Securities Registration Statement (S-1) | | | |
| Very informative video with the CEO (must press play button)
skip the chit-chat and start viewing at 3:20
The real meat and potatoes on the dilution-debt-pps starts at 4:50 or so.
Basically this is what he did #msg-45180867
NEW PARTNER - Letter of Intent to process and store cord blood specimens for BioCells, Inc. dated 01-04-2010 
SEC Filings:
| | Form Type  | Received  | Period | | 4 | 1/14/2010 | 1/4/2010 |  | | 4 | 1/14/2010 | 12/31/2009 | | | 4 | 1/14/2010 | 12/31/2009 | | | 8-K/A | 1/12/2010 | 1/6/2010 | | | 8-K | 1/11/2010 | 1/6/2010 | | | 8-K | 1/7/2010 | 12/31/2009 | | | S-1 | 12/31/2009 | N/A | | | S-8 | 12/30/2009 | N/A | | | RW | 12/29/2009 | N/A | | | 10-Q | 11/13/2009 | 9/30/2009 | | | S-1 | 11/2/2009 | N/A | | | RW | 10/29/2009 | N/A | | | 8-K/A | 10/29/2009 | 7/2/2009 | | | 10-Q | 8/14/2009 | 6/30/2009 | | | S-1 | 8/3/2009 | N/A | | | 8-K | 7/17/2009 | 7/13/2009 | | | 8-K | 7/8/2009 | 7/2/2009 | | | 8-K | 6/30/2009 | 6/23/2009 | | | EFFECT | 5/27/2009 | N/A | | | 10-Q | 5/20/2009 | 3/31/2009 | | | | H.R. Bill 2107 and 1718;
to Educate and Grant Tax Credits towards
Private Cord Blood Banking
H.R. 2107 ~ National Education Initiative regarding Cord blood Banking. Not later than [1] year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this Act referred to as the ‘Secretary’) shall develop and make publicly available, including by posting on the public website of the Department of Health and Human Services, a publication relating to umbilical cord blood.
http://www.opencongress.org/bill/111-h2107/text
- H.R. 1718 ~ Tax Credit For Related Private Cord Blood Banking. To amend the Internal Revenue Code of 1986 to treat amounts paid for umbilical cord blood banking services as medical care expenses.
http://www.opencongress.org/bill/111-h1718/text
| |
fox news video: Cord Blood Miracle November 9, 2009
BBC video: Stem cells Stem cells 'Bring hope of a cure' October 27, 2009
| FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2009 AND 2008
| | | | | | | | | | | | | THREE-MONTH
PERIOD | | | THREE-MONTH
PERIOD | | | | | ENDED | | | ENDED | | | | | SEPTEMBER 30, | | | SEPTEMBER 30, | | | | | 2009 | | | 2008 | | | Revenue | | $ | 838,238 | | | 927,359 | | | | Cost of services | | | (203,507 | ) | | (449,937 | | ) | | Gross profit | | | 634,731 | | | 477,422 | | | | Administrative and selling expenses | | | (1,579,450 | ) | | (942,045 | | ) | | Loss from Operations | | | (944,719 | ) | | (464,623 | | ) | | Interest expense and change in derivative liability | | | (1,353,924 | ) | | (1,146,019 | | ) | | Net loss before income taxes | | | (2,298,943 | ) | | (1,610,642 | | ) | | Income taxes | | | –– | | | –– | | | | Net loss | | | (2,298,943 | ) | | (1,610,642 | | ) | | Basic and diluted loss per share | | $ | (0.00 | ) | | (0.01 | | ) | | Weighted average common shares outstanding | | | 2,775,994,889 | | | 258,075,887 | | | |
| SELLING STOCKHOLDER (from the S-1 filed 12/31/2009) All of the shares of common stock registered for sale pursuant to this prospectus are shares issuable upon exercise of a warrant owned by the selling stockholder, acquired in connection with an Amended and Restated Stock Purchase Agreement dated December 30, 2009, between us and Optimus Life Sciences Capital Partners, LLC, an affiliate of the selling stockholder. We have agreed to pay all expenses and costs to comply with our obligation to register the selling stockholder’s shares of common stock. We have also agreed to indemnify and hold harmless the selling stockholder against certain losses, claims, damages or liabilities, joint or several, arising under the Securities Act of 1933. The following table sets forth the name of the selling stockholder, the number of shares of common stock beneficially owned by the selling stockholder immediately prior to the date of this prospectus (assuming that we sell all $7.5 million of Series A Preferred Stock and that those sales take place at times when our stock price is $0.0125 per share) and the total number of shares that may be offered pursuant to this prospectus. The table also provides information regarding the beneficial ownership of our common stock by the selling stockholder as adjusted to reflect the assumed sale of all of the shares offered under this prospectus. Percentage of beneficial ownership before this offering is based on 4,886,468,478 shares of our common stock outstanding as of December 30, 2009. The selling stockholder may offer the shares for sale from time to time in whole or in part. Except where otherwise noted, the selling stockholder named in the following table has, to our knowledge, sole voting and investment power with respect to the shares beneficially owned by it. | | | | | | | | | | | | | | | | | | | | | | | | | Beneficial Ownership Before Offering | | | | | | | | Number of Shares | | | | | | Number of
Shares Being | | Beneficial Ownership
After Offering | | Selling Stockholder | | Owned | | Percent | | Registered | | Shares | | Percent | | Optimus CG II, Ltd. (1) | | | 840,000,000 (2) | | | | 17.19 | % | | | 840,000,000 | | | | — | | | | * | | |
 |  |
souce: S1 filed Aug 14, 2009
On February 28, 2007, Cord Blood America, Inc.. acquired CorCell, Inc
On August 20, 2007 Cord Blood America, Inc.. acquired Cure Source Inc.
On August 1, 2007, it entered into an agreement with Progenitor Cell Therapy, LLC (PCT) for testing, processing and storage of cord blood samples
Cord Blood America is the parent company of Cord Partners, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children.
CEO says CBAI is the 4th largest in the USA (at min 6:23) and about the 20th largest of about 150 companies worldwide. Plans on more acquisitions. http://www.youtube.com/watch?v=ZTxLegm7M5Y
Cord Blood America, Inc. CBAI.OB
http://www.cordbloodbermuda.com/index.html
Website:
http://www.cordblood-america.com
Corporate Address:
9000 W. Sunset Boulevard
Suite 400
West Hollywood, CA 90069 USA
Company Contact:
P:(310) 432-4090
F:(310) 432-4098
investors@cordblood-america.com
Investor relations:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
Share Structure History:
AS: 6.945B ( upped from 950M on 03-23-2009 per proxy statement )
AS: 950M ( upped from 300M on 08-28-2008, see #msg-31499433 )
AS: 300M
OS: 4,886,468,478 as of Dec 31, 2009 (per 12/31/09 S-1 dilution of 318M in the last 50days )
OS: 4,568,253,327 as of Nov 09, 2009 (per 11/03/09 10Q - dilution of 1.95B in the lst 3 months)
OS: 2,611,087,327 Aug 10, 2009 (per 8/14/09 10Q - dilution of 1.03B in 3 months)
OS: 1,579,096,424 May 15, 2009 (per 10Q - dilution of 636M in 3 months)
OS: 942,884,111 Feb 12, 2009 (per proxy statement - dilution of 634M in 3 months) - Most of this has been sold through mm NITE & HDSN
OS: 309,474,243 Nov 10, 2008 (per 10Q - dilution of 85M in 4 months)
OS: 224,699,718 Jul 08, 2008 (per 8/04/08 proxy statement)
OS: 225,154,440 Apr 07, 2008 (per 10k, dilution of 30M in 4 months)
OS: 195,558,923 Dec 31, 2007 (dilution of 21M)
OS: 174,048,335 Nov 11, 2007 (dilution of 9M)
OS: 165,372,807 Sept 30, 2007 (dilution of 6M)
OS: 159,055,819 Aug 14, 2007 (dilution of 73M)
OS: 85,565,249 May 18, 2007 (dilution of 37M)
OS: 49,118,075 Apr 02, 2007 dilution of 8M)
OS: 41,091,845 Nov 10, 2006
Transfer Agent
Interwest Transfer Company, Inc. (gagged - TA says to call the company for this info. Ph: 310-432-4090)
1981 East 4800 South
Suite 100
Salt Lake City, UT 84117
Phone: (801) - 272-9294
Fax: (801) - 277-3147
Websites:
http://www.cordblood-america.com
http://www.cordpartners.com
http://www.cord-blood-video.com
http://www.curesource.net
http://www.corcell.com
Primary State of Incorporation: Florida
http://www.sunbiz.org/pdf/90403269.pdf
Fiscal Year End: December 31
Company Officers:
Mathew Schissler Chief Executive Officer Founder and Chairman
Joseph Vicente Chief Operating Officer - Director
Brian Pockett Vice President Operations
Marion Malone Vice President Business Development
Dr. Geoffrey O'Neill Director Stem Cell Lab
Business Description:
Top institutional holders:
 |
source (above): S-1 filed Aug 3, 2009 http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=6726062
Top Holders from the 02-13-2009 Proxy (Enable et el are the PIPE sellers)
Top holders from the proxy statement filed 08/04/08...
SEC filing History:
http://www.pinksheets.com/quote/filings.jsp?symbol=CBAI
http://sec.gov/cgi-bin/browse-edgar?company=CORD+BLOOD+AMERICA&action=getcompany
CHARTS
5 day...
3 month daily... (accumulation looking good while the pps weakens)
6 month daily...
1 year weekly...
3 year weekly...
Press History:
http://finance.yahoo.com/q?s=CBAI.OB
http://ih.advfn.com/p.php?pid=squote&symbol=CBAI
http://www.smallcapwatch.com/company.asp?TICKER=cbai
| Recent News |
| Date | Time | |
| 01/07/2010 | 5:03PM | Current report filing (8-K) |
| 01/06/2010 | 9:00AM | (OTC: KKUR) Mayo Clinic Research Proves and Confirms ChromoCure's Technology |
| 01/05/2010 | 10:04AM | CEO of Cord Blood America (OTCBB: CBAI) Reveals His Company Has Voracious Appetite for Growth, Expansion and Acquisitions |
| 12/31/2009 | 12:05PM | Securities Registration Statement (S-1) |
| 12/30/2009 | 1:43PM | Securities Registration: Employee Benefit Plan (S-8) |
| 12/29/2009 | 12:59PM | Withdrawal of Registration Statement (RW) |
| 12/04/2009 | 5:00AM | MoneyTV With Donald Baillargeon, 12/4 |
| 11/13/2009 | 4:52PM | Quarterly Report (10-Q) |
| 11/03/2009 | 1:37PM | Securities Registration Statement (S-1) |
| 10/29/2009 | 4:43PM | Withdrawal of Registration Statement (RW) |
| 10/23/2009 | 5:00AM | MoneyTV with Donald Baillargeon, 10/23 |
| 10/01/2009 | 9:15AM | Market Pulse Announces Its Hot Stock Alerts for Thursday, October 1, 2009: MNGA, AMZN, CBAI, MA |
| 09/30/2009 | 10:58AM | MNDP Sees Huge Potential in Aerial Rescue |
| 09/25/2009 | 5:00AM | MoneyTV with Donald Baillargeon, 9/25 |
| 08/07/2009 | 5:00AM | 8/7, MoneyTV with Donald Baillargeon |
| 08/03/2009 | 5:38PM | Securities Registration Statement (S-1) |
| 07/17/2009 | 4:12PM | Current report filing (8-K) |
| 07/10/2009 | 5:00AM | 7/10, MoneyTV with Donald Baillargeon |
| 07/08/2009 | 4:30PM | Current report filing (8-K) |
| 06/30/2009 | 6:03AM | Current report filing (8-K) |
.JPG)
, 
, 
, 
, 
.JPG)
